The Cooper Companies, Inc.

COO

$55.38

Name : The Cooper Companies, Inc.

Sector : Healthcare

Industry: Medical Instruments & Supplies

Mark. Cap: $10,530,800,640.00

EPSttm : 2.91

The Cooper Companies, Inc.

$55.38

0.00%

$0.00000000000000

COO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.3

Margin Of Safety %

Put/Call OI Ratio

0.36

EPS Next Q Diff

-0.05

EPS Last/This Y

2.65

EPS This/Next Y

0.16

Price

55.38

Target Price

65.85

Analyst Recom

2.32

Performance Q

-22.02

Upside

-31.2%

Beta

0.82

Ticker: COO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	COO	71.17	0.15	0.01	12430
2026-08-31	COO	70.08	0.15	0.14	12653
2026-09-01	COO	69.29	0.15	2.65	12631
2026-09-02	COO	69.71	0.15	0.06	12666
2026-09-03	COO	70.65	0.15	0.01	12628
2026-09-04	COO	69.58	0.16	9.00	12517
2026-09-08	COO	67.69	0.20	1.33	13004
2026-09-09	COO	63.06	0.21	1.57	13252
2026-09-10	COO	54.17	0.65	2.27	27699
2026-09-11	COO	53.88	0.46	0.77	27570
2026-09-14	COO	54.21	0.47	0.45	28906
2026-09-15	COO	53.28	0.43	0.19	29326
2026-09-16	COO	54.62	0.41	0.68	29582
2026-09-17	COO	53.78	0.44	4.20	30364
2026-09-18	COO	55.21	0.40	0.63	30343
2026-09-21	COO	54.12	0.40	0.26	21127
2026-09-22	COO	55.29	0.40	0.62	21488
2026-09-23	COO	56.06	0.40	1.75	21812
2026-09-24	COO	55.39	0.36	0.27	21156
2026-09-25	COO	55.39	0.36	0.19	21223
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	COO	71.15	1.9	386.4	4.63
2026-08-31	COO	70.08	1.8	372.7	4.63
2026-09-01	COO	69.25	1.8	375.2	4.63
2026-09-02	COO	69.72	1.8	389.1	4.63
2026-09-03	COO	70.53	1.8	393.0	4.63
2026-09-04	COO	69.57	1.8	372.9	4.63
2026-09-08	COO	67.70	1.8	363.7	4.63
2026-09-09	COO	63.42	1.8	336.5	4.63
2026-09-10	COO	54.20	1.8	274.0	4.63
2026-09-11	COO	53.89	1.8	334.5	4.63
2026-09-14	COO	54.19	1.8	317.2	4.63
2026-09-15	COO	53.28	-7.2	301.5	4.53
2026-09-16	COO	53.28	-7.2	301.5	4.53
2026-09-17	COO	53.78	-2.6	302.6	4.53
2026-09-18	COO	55.31	-2.6	333.3	4.53
2026-09-21	COO	54.12	-2.6	298.2	4.53
2026-09-22	COO	55.30	-2.6	328.7	4.53
2026-09-23	COO	56.06	-2.6	323.0	4.53
2026-09-24	COO	55.39	-2.6	304.8	4.53
2026-09-25	COO	55.38	-2.6	313.1	4.53
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	COO	0.00	1.59	3.94
2026-08-31	COO	0.00	2.13	3.94
2026-09-01	COO	0.00	2.13	3.94
2026-09-02	COO	0.00	2.13	3.94
2026-09-03	COO	0.00	2.13	3.94
2026-09-04	COO	0.00	2.13	3.94
2026-09-08	COO	0.00	2.30	3.94
2026-09-09	COO	0.00	2.30	3.94
2026-09-10	COO	0.00	2.30	3.94
2026-09-11	COO	0.00	2.30	4.53
2026-09-14	COO	0.00	2.37	4.65
2026-09-15	COO	0.00	2.37	4.65
2026-09-16	COO	2.21	2.37	4.65
2026-09-17	COO	2.21	2.37	4.65
2026-09-18	COO	3.14	2.37	4.65
2026-09-21	COO	3.14	2.37	4.65
2026-09-23	COO	3.03	2.37	4.65
2026-09-24	COO	3.03	2.37	4.65
2026-09-25	COO	3.03	2.37	5.30
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.15

Avg. EPS Est. Current Quarter

1.12

Avg. EPS Est. Next Quarter

1.1

Insider Transactions

3.03

Institutional Transactions

2.37

Beta

0.82

Average Sales Estimate Current Quarter

1067

Average Sales Estimate Next Quarter

1053

Fair Value

89.14

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

50.7

Max Drawdown 5-Year %

-52.1

Target Price

65.85

P/E

18.9

Forward P/E

11.77

PEG

1.59

P/S

2.49

P/B

1.26

P/Free Cash Flow

15.53

EPS

2.93

Average EPS Est. Cur. Y

4.53

EPS Next Y. (Est.)

4.69

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.46

Relative Volume

1.49

Return on Equity vs Sector %

-19.4

Return on Equity vs Industry %

-2.8

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.1

EBIT Estimation

313.1

◆ COO Healthcare

$55.38

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

23/25

Volume

0/15

Valuation

18/20

TP/AR

1/10

Options

8/10

RSI

30.3

Range 1M

19%

Sup Dist

1.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

12/30

Estimates

6/20

Inst/Vol

6/15

Options

8/10

EPS Yr

10.3%

EPS NY

3.6%

52W%

10.7%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +27.1% upside

Quality

11/30

Valuation

16/30

Growth

10/25

Stability

6/10

LT Trend

4/5

Upside

+27.1%

Quality

MoS

61%

COO — P/E HistoricalMedical Instruments & Supplies

The Cooper Companies, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 15000

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

COO

Latest News

—

Caricamento notizie per COO…

stock quote shares COO – The Cooper Companies, Inc. Stock Price stock today

news today COO – The Cooper Companies, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch COO – The Cooper Companies, Inc. yahoo finance google finance

stock history COO – The Cooper Companies, Inc. invest stock market

stock prices COO premarket after hours

ticker COO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: COO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y